FDA NDA · NDA221154

HOVILPR

Sponsor: AICURIS ANTI-INFECTIVE CURES AG

What this page does not claim

A drug page is a reference view of public FDA data (Drugs@FDA), reproduced as published. SPEQ is not affiliated with the FDA, adds no interpretation to the record, and nothing here is medical, legal, or regulatory advice.

APPLICATION
NDA221154
TYPE
NDA
ORIGINAL APPROVAL
2026-10-09
LATEST ACTION
2026-10-09
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

HOVILPRPrescription
PRITELIVIR 100MG · TABLET · ORAL

Approval history

2026-10-09Type 1 - New Molecular Entity · Original · priority — Label ↗AP